Natural History of Cardiac and Respiratory Involvement, Prognosis and Predictive Factors for Long-Term Survival in Adult Patients with Limb Girdle Muscular Dystrophies Type 2C and 2D-Reference-Cited by-同舟云学术

Natural History of Cardiac and Respiratory Involvement, Prognosis and Predictive Factors for Long-Term Survival in Adult Patients with Limb Girdle Muscular Dystrophies Type 2C and 2D

Published:2016-04-27 Issue:4 Volume:11 Page:e0153095
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Fayssoil Abdallah,Ogna Adam,Chaffaut Cendrine,Chevret Sylvie,Guimarães-Costa Raquel,Leturcq France,Wahbi Karim,Prigent Helene,Lofaso Frederic,Nardi Olivier,Clair Bernard,Behin Anthony,Stojkovic Tanya,Laforet Pascal,Orlikowski David,Annane Djillali

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference39 articles.

1. Mutations in the dystrophin-associated protein gamma-sarcoglycan in chromosome 13 muscular dystrophy;S Noguchi;Science,1995

2. Missense mutations in the adhalin gene linked to autosomal recessive muscular dystrophy;SL Roberds;Cell,1994

3. Sarcoglycanopathies: molecular pathogenesis and therapeutic prospects;D Sandonà;Expert Rev Mol Med,2009

4. Prolongation of life in Duchenne’s muscular dystrophy;Y Rideau;Acta Neurol (Napoli),1983

5. Prognostic evaluation of congestive heart failure in patients with Duchenne muscular dystrophy—retrospective study using non-invasive cardiac function tests;T Nagai;Jpn Circ J,1989

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Phenotypic Variability of LGMD 2C/R5 in a Genetically Homogenous Group of Bulgarian Muslim Roma;Genes;2024-08-30

2. Advanced Heart Failure Therapies in Neuromuscular Diseases;Current Treatment Options in Cardiovascular Medicine;2024-06-25

3. Is Cardiac Transplantation Still a Contraindication in Patients with Muscular Dystrophy-Related End-Stage Dilated Cardiomyopathy? A Systematic Review;International Journal of Molecular Sciences;2024-05-13

4. Defining clinical endpoints in limb girdle muscular dystrophy: a GRASP-LGMD study;BMC Neurology;2024-03-15

5. Gene therapy with bidridistrogene xeboparvovec for limb-girdle muscular dystrophy type 2E/R4: phase 1/2 trial results;Nature Medicine;2024-01